Your browser doesn't support javascript.
loading
Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
Ellwardt, Erik; Pramanik, Gautam; Luchtman, Dirk; Novkovic, Tanja; Jubal, Eduardo Rosales; Vogt, Johannes; Arnoux, Isabelle; Vogelaar, Christina Francisca; Mandal, Shibajee; Schmalz, Melanie; Barger, Zeke; Ruiz de Azua, Inigo; Kuhlmann, Tanja; Lutz, Beat; Mittmann, Thomas; Bittner, Stefan; Zipp, Frauke; Stroh, Albrecht.
Afiliação
  • Ellwardt E; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Pramanik G; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Luchtman D; Focus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Novkovic T; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Jubal ER; Focus Program Translational Neurosciences & Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Vogt J; Focus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Arnoux I; Focus Program Translational Neurosciences & Institute for Microscopic Anatomy and Neurobiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Vogelaar CF; Focus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Mandal S; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Schmalz M; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Barger Z; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Ruiz de Azua I; Focus Program Translational Neurosciences & Institute of Pathophysiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Kuhlmann T; Focus Program Translational Neurosciences & Institute for Physiological Chemistry, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Lutz B; Institute for Neuropathology, University Hospital Münster, Münster, Germany.
  • Mittmann T; Focus Program Translational Neurosciences & Institute for Physiological Chemistry, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Bittner S; Focus Program Translational Neurosciences & Institute of Physiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Zipp F; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Stroh A; Department of Neurology Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn²), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. frauke.zipp@unimedizin-mainz.de.
Nat Neurosci ; 21(10): 1392-1403, 2018 10.
Article em En | MEDLINE | ID: mdl-30258239
ABSTRACT
Multiple sclerosis (MS) patients exhibit neuropsychological symptoms in early disease despite the immune attack occurring predominantly in white matter and spinal cord. It is unclear why neurodegeneration may start early in the disease and is prominent in later stages. We assessed cortical microcircuit activity by employing spiking-specific two-photon Ca2+ imaging in proteolipid protein-immunized relapsing-remitting SJL/J mice in vivo. We identified the emergence of hyperactive cortical neurons in remission only, independent of direct immune-mediated damage and paralleled by elevated anxiety. High levels of neuronal activity were accompanied by increased caspase-3 expression. Cortical TNFα expression was mainly increased by excitatory neurons in remission; blockade with intraventricular infliximab restored AMPA spontaneous excitatory postsynaptic current frequencies, completely recovered normal neuronal network activity patterns and alleviated elevated anxiety. This suggests a dysregulation of cortical networks attempting to achieve functional compensation by synaptic plasticity mechanisms, indicating a link between immune attack and early start of neurodegeneration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Córtex Cerebral / Recuperação de Função Fisiológica / Encefalomielite Autoimune Experimental / Hipercinese Limite: Animals Idioma: En Revista: Nat Neurosci Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Córtex Cerebral / Recuperação de Função Fisiológica / Encefalomielite Autoimune Experimental / Hipercinese Limite: Animals Idioma: En Revista: Nat Neurosci Ano de publicação: 2018 Tipo de documento: Article